Targeted protein degradation as a powerful research tool in basic biology and drug target discovery

被引:107
|
作者
Wu, Tao [1 ,2 ]
Yoon, Hojong [1 ,2 ]
Xiong, Yuan [1 ,2 ]
Dixon-Clarke, Sarah E. [1 ,2 ]
Nowak, Radoslaw P. [1 ,2 ]
Fischer, Eric S. [1 ,2 ]
机构
[1] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA
[2] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA
关键词
E3 UBIQUITIN LIGASE; STRUCTURAL BASIS; SELECTIVE DEGRADATION; RBM39; RECRUITMENT; COP9; SIGNALOSOME; LENALIDOMIDE; THALIDOMIDE; CANCER; INHIBITOR; MOLECULES;
D O I
10.1038/s41594-020-0438-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Controlled perturbation of protein activity is essential to study protein function in cells and living organisms. Small molecules that hijack the cellular protein ubiquitination machinery to selectively degrade proteins of interest, so-called degraders, have recently emerged as alternatives to selective chemical inhibitors, both as therapeutic modalities and as powerful research tools. These systems offer unprecedented temporal and spatial control over protein function. Here, we review recent developments in this field, with a particular focus on the use of degraders as research tools to interrogate complex biological problems. Small molecules that hijack the cellular protein ubiquitination machinery to selectively degrade proteins of interest have emerged as therapeutic modalities and powerful research tools. This Review summarizes recent developments in this field, with a focus on the use of degraders as research tools.
引用
收藏
页码:605 / 614
页数:10
相关论文
共 50 条
  • [41] Targeted Covalent Inhibitors in Drug Discovery, Chemical Biology and Beyond
    Serafim, Ricardo A. M.
    Gehringer, Matthias
    Borsari, Chiara
    [J]. PHARMACEUTICALS, 2024, 17 (02)
  • [42] Cell-Penetrating Peptides: A Powerful Tool for Targeted Drug Delivery
    Kotadiya, Dushyant D.
    Patel, Piyushkumar
    Patel, Hitesh D.
    [J]. CURRENT DRUG DELIVERY, 2023, 21 (03) : 368 - 388
  • [43] Targeted Protein Degradation: The New Frontier of Antimicrobial Discovery?
    Powell, Matthew
    Blaskovich, Mark A. T.
    Hansford, Karl A.
    [J]. ACS INFECTIOUS DISEASES, 2021, 7 (08): : 2050 - 2067
  • [44] Structural biology and drug discovery for protein-protein interactions
    Jubb, Harry
    Higueruelo, Alicia P.
    Winter, Anja
    Blundell, Tom L.
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2012, 33 (05) : 241 - 248
  • [45] Discovery of New Binders for DCAF1, an Emerging Ligase Target in the Targeted Protein Degradation Field
    Vulpetti, Anna
    Holzer, Philipp
    Schmiedeberg, Niko
    Imbach-Weese, Patricia
    Pissot-Soldermann, Carole
    Hollingworth, Gregory J.
    Radimerski, Thomas
    Thoma, Claudio R.
    Stachyra, Therese-Marie
    Wojtynek, Matthias
    Maschlej, Magdalena
    Chau, Suzanne
    Schuffenhauer, Ansgar
    Fernandez, Cesar
    Schroder, Martin
    Renatus, Martin
    [J]. ACS MEDICINAL CHEMISTRY LETTERS, 2023, 14 (07): : 949 - 954
  • [46] Protein methyltransferases as a target class for drug discovery
    Robert A. Copeland
    Michael E. Solomon
    Victoria M. Richon
    [J]. Nature Reviews Drug Discovery, 2009, 8 : 724 - 732
  • [47] Protein methyltransferases as a target class for drug discovery
    Copeland, Robert A.
    Solomon, Michael E.
    Richon, Victoria M.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (09) : 724 - 732
  • [48] Oligonucleotide synthesis as a tool in drug discovery research
    Marshall, WS
    Boymel, JL
    [J]. DRUG DISCOVERY TODAY, 1998, 3 (01) : 34 - 42
  • [49] Bivalent Ligands for Protein Degradation in Drug Discovery
    Scheepstra, Marcel
    Hekking, Koen F. W.
    van Hijfte, Luc
    Folmer, Rutger H. A.
    [J]. COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2019, 17 : 160 - 176
  • [50] Target identification and mechanism of action in chemical biology and drug discovery
    Schenone M.
    Dančík V.
    Wagner B.K.
    Clemons P.A.
    [J]. Nature Chemical Biology, 2013, 9 (4) : 232 - 240